Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers.
- Published In:
- Anti-cancer agents in medicinal chemistry, 7(5), 552-8 (2007)
- Authors:
- Garanger, Elisabeth, Boturyn, Didier, Dumy, Pascal
- Database ID:
- RPEP-01228
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01228APA
Garanger, Elisabeth; Boturyn, Didier; Dumy, Pascal. (2007). Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers.. Anti-cancer agents in medicinal chemistry, 7(5), 552-8.
MLA
Garanger, Elisabeth, et al. "Tumor targeting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancers.." Anti-cancer agents in medicinal chemistry, 2007.
RethinkPeptides
RethinkPeptides Research Database. "Tumor targeting with RGD peptide ligands-design of new molec..." RPEP-01228. Retrieved from https://rethinkpeptides.com/research/garanger-2007-tumor-targeting-with-rgd
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.